Gliomas arise from the brain's support cells, not the nerve cells themselves.
In short: While nerve cells conduct impulses, the brain's most abundant cells are glial cells, which provide vital support and nourishment. When these cells undergo DNA changes that cause them to multiply uncontrollably, they form gliomas. These tumors can be slow-growing or highly aggressive, presenting a complex challenge for modern medicine.
The human brain is primarily composed of glial cells, which maintain the environment for nerve cells to function. Gliomas are tumors that originate from these glial cells, specifically astrocytes, oligodendroglia, or ependymal cells. Because these tumors arise from the very cells meant to support brain tissue, they are inherently infiltrative, often blending into the surrounding healthy brain matter. This makes complete surgical removal exceptionally difficult, as surgeons must balance the need to excise the tumor against the risk of causing permanent neurological injury.
Clinicians classify gliomas using the World Health Organization grading system, which ranges from I to IV based on growth rate and invasiveness. Grade I and II tumors are generally considered low-grade and slow-growing, though they often recur due to their infiltrative nature. Conversely, Grade III and IV tumors are high-grade and aggressive. Glioblastoma multiforme, a Grade IV tumor, is the most common and malignant primary brain tumor in adults. It typically presents in patients around 55 years of age and spreads rapidly, making it one of the most challenging conditions in neuro-oncology.
The exact cause of these tumors remains unknown, though research points to DNA damage as a primary driver. When DNA repair mechanisms fail—sometimes due to inherited polymorphisms or epigenetic silencing of genes like MGMT—cells may gain a proliferative advantage, leading to tumor formation. While ionizing radiation is a known risk factor, most cases occur sporadically. Treatment typically involves a combination of surgery, radiation, and chemotherapy, such as temozolomide. Despite these interventions, the infiltrative nature of high-grade gliomas often necessitates a focus on symptom management and quality of life, as curative options remain limited for the most aggressive variants.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Glioma (Astrocytoma) | North Bristol NHS Trust
- Also: Glioma - Symptoms and causes
- Also: Glioma
To cite this card, link to https://intellectplus.co.uk/app/health-glioma.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics
